Health Promotion and Intervention at the Individual Level – HPII
NOTE: Starts with the October 2026 Council round submission dates (Cycle I due dates). This study section was evaluated as part of CSR’s ENQUIRE process to align study sections with advances in science. Learn more about ENQUIRE.
Scientific Review Officer
This study section reviews social and behavioral individual level/person-centered interventions involving the uptake or adoption of health behaviors intended to prevent exposure to a disease/condition, and reduce harm, and promote recovery. All studies are in human populations. Population based studies, and studies proposing the use of pharmacotherapies are reviewed in other study sections. Applications with a physiological and biological basis, basic science, or an animal model focus are reviewed in other study sections. Small group-level interventions, community-level interventions, local area/place-based interventions, system-level interventions, and studies with a policy/public health focus are reviewed in other study sections.
Review Dates
A roster for the panel will be posted here, at least 30 days prior to the review meeting
Membership Panel
When the panel is chartered as a standing panel, members will be listed here. Expected in 2026.
Topics
- Interventions to improve mental/cognitive health and psychological well-being (social and emotional well-being, intellectual functioning, social isolation, depression);
- Interventions promoting the uptake of safer drug use behaviors among individuals;
- Interventions to improve health and prevent/reduce harm for conditions such as disordered/dysregulated eating, gaming, mental health, substance misuse and other behaviors;
- Individual interventions to improve health and prevent/reduce harm related to violence, intimate partner violence, aggression, and suicidal behavior;
- Individual interventions examining social, emotional, and/or cognitive development and attempting to improve a specific behavior or health outcome (e.g., academic outcomes, bullying).
